Emirates Drug Establishment approves new indication for Foundayo to treat type 2 diabetes
The move makes the UAE the world’s third country to approve the medicine for this use
WAM1 min read
Share

Foundayo is an oral, non-peptide glucagon-like peptide-1 (GLP-1) receptor agonist taken once daily without food or water restrictions. File photograph
Add Emirates 24|7 to your Google News
Text Size:
